Reprise Biomedical
Dr. Isenburg has served as the Vice President of Research & Development for Reprise since June 2019. From 2010 through May 2019, Dr. Isenburg was employed at Vascular Solutions, Inc. first as a Senior Biological Development Scientist and, following the company’s acquisition by Teleflex Incorporated, as Director of Scientific Affairs. Previous to Vascular Solutions, from 2007 to 2010, Dr. Isenburg served as a Senior Research Scientist at Vatrix Medical, a start-up medical device company based on his own patented research, with a focus on the diagnosis and treatment of aneurysms. Dr. Isenburg holds a Ph.D. in Bioengineering from Clemson University and a B.S. in Chemical Engineering from Rose-Hulman Institute of Technology.
This person is not in any offices
Reprise Biomedical
Reprise Biomedical is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019.